News

Published on 9 Apr 2024 on Benzinga

...At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' - Abbott...


Article preview image

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories ABT over Penumbra, Inc. PEN.

"I still fear it after the environmental damage. I am concerned that you can’t really put a price on it," Cramer said when asked about Hawaiian Electric Industries, Inc. HE. "I think that the fires were too great, and therefore the stock could still go lower."

NYSE.EMR price evolution
NYSE.SBSW price evolution
NASDAQ.VRTX price evolution
NYSE.ABT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Abbott Laboratories (NYSE:ABT) is largely controlled by institutional...

Ownership Tell Us About Abbott Laboratories? Institutions typically measure themselves against a...

Simply Wall St. · via Yahoo Finance 24 Nov 2024

2 Dividend Kings to Buy for a Lifetime of Passive Income

Dividend Kings are among the best income stocks on the market. Let's consider two companies in th...

Motley Fool · via Yahoo Finance 22 Nov 2024

Major companies that are also popular short-selling stocks

Investor confidence in certain major companies has propelled markets higher, but there are also...

Yahoo Finance UK 21 Nov 2024

DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring

So the companies are seeing if Type-2 diabetes patients and health-conscious folks will pay...

Barrons.com 20 Nov 2024

Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise

Medtronic stock slumped Tuesday despite beating fiscal second-quarter expectations after a suppli...

Investor's Business Daily 19 Nov 2024

Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now

We recently compiled a list of the 8 Magnificent Dividend Growth Stocks to Buy Now. In this artic...

Insider Monkey · via Yahoo Finance 17 Nov 2024

Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment

AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stag...

Insider Monkey · via Yahoo Finance 16 Nov 2024

Dividend King AbbVie Just Paid Investors: Here's How Much They Got

AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of...

247wallst.com 16 Nov 2024

Abbott extends executive agreements through 2026 By Investing.com

Abbott Laboratories (NYSE:ABT), a key player in the pharmaceutical industry, has announced the...

Investing.com 15 Nov 2024

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100...

Its dividend yields 3%, and if your priority is to generate a safe and recurring dividend, Coca-C...

Motley Fool · via Yahoo Finance 14 Nov 2024